Your report
Lash Growth Bottleneck Report
Your personalized report will appear here after email capture.
--
Bottleneck load
Scorecard
Your 30/60/90 day plan
Recommendation
Sources and guardrails
- Lash growth has a normal cycle. A short trial can miss the visible growth window.
- Prescription bimatoprost is FDA-approved for hypotrichosis, but prostaglandin-class products carry eye-area side effect warnings.
- Health Canada lists isopropyl cloprostenate as a restricted/prohibited cosmetic ingredient concern. Ingredient names can be technical, so label scanning matters.
- Sudden lash loss, irritation, pain, or patches deserve clinician review. This report cannot rule out blepharitis, allergy, alopecia, thyroid issues, medication effects, or other medical causes.